Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance.
about
Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury.Hepatocyte and keratinocyte growth factors and their receptors in human lung emphysemaPediatric Acute Respiratory Distress Syndrome: Fibrosis versus RepairA Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress SyndromeThe fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling.Hepatocyte growth factor levels in Legionella pneumonia: a retrospective studyEpithelial repair mechanisms in the lungPalifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.Asef controls vascular endothelial permeability and barrier recovery in the lung.Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.Regulation of hepatocyte growth factor in mice with pneumonia by peptidases and trans-alveolar flux.Proteomics: current techniques and potential applications to lung disease.Biomarkers in acute lung injury.Role of chemokines in the pathogenesis of acute lung injury.Protection of epithelial cells by keratinocyte growth factor signalingMast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonistsHepatocyte growth factor regulates angiotensin converting enzyme expressionMagnitude-dependent effects of cyclic stretch on HGF- and VEGF-induced pulmonary endothelial remodeling and barrier regulationIGF1 and IGFBP3 in acute respiratory distress syndromeThe pathogenetic and prognostic value of biologic markers in acute lung injury.Diverse macrophage populations mediate acute lung inflammation and resolution.Novel therapeutic strategies for acute lung injury induced by lung damaging agents: the potential role of growth factors as treatment options.Cellular therapies for lung disease: a distant horizon.Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.Repair after acute lung injury: molecular mechanisms and therapeutic opportunities.Growth factors and cytokines in acute lung injury.Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development.Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury.Keratinocyte growth factor (KGF) decreases ICAM-1 and VCAM-1 cell expression on bronchial epithelial cells.Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism.Alveolar epithelial fluid transport can be simultaneously upregulated by both KGF and beta-agonist therapy.Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycinHepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure.Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.Keratinocyte growth factor promotes preadipocyte proliferation via an autocrine mechanism.Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.Cytokine-Ion Channel Interactions in Pulmonary Inflammation.Is cell therapy in acute lung injury a realistic dream?Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.
P2860
Q24800694-3A37066F-5FD6-4987-AA6B-16479198C603Q24810626-BE595704-E2AF-4EFD-B15F-6D6828C90F4AQ26749366-BC0A382F-38A9-4808-9588-D92D2B5B3286Q26765351-4D968247-5C05-4124-9C5C-EB5EC66B3034Q33586556-50170B38-2CC0-479C-90CC-A5D2F8311FCFQ33840378-6B175DD0-6583-40AC-A6DB-7FD357CF3040Q33853273-7B8800D8-E603-4994-8182-28BD1DB19790Q33916933-4205D5EB-4E02-4A18-A33C-AD37B2733E63Q33985578-347F5266-8049-46BE-AE6A-05FFC042F7ACQ35077012-BFEE193A-5F86-4352-ABF1-18835E0EB55EQ35138639-0563DC7F-ADC6-40F5-8A3A-CB5DA8E2C36CQ35566385-4BB90E7D-2CB0-4C4F-B3B4-9A7CE16D1EE2Q35798681-FC8990B5-86F0-4214-ADA3-D89838B3C23BQ35958312-03DF6B34-A15B-4059-B4C2-B6FBF8D20F9EQ35991282-15583EA7-945C-438F-B682-7042AF1A37D8Q36284871-BFD4F344-9F40-470F-8610-28C17EC6B65EQ36503129-3CB4159D-DF10-4A7C-9D24-ECECACA1C849Q36740263-AD8BCA35-7134-47B7-8AB8-1E9DB3FBB411Q36956180-D4E60C48-36F5-408E-9423-9F0CD9722B50Q37133007-7BA09744-126E-41FB-86B6-85FDF6F680BAQ37413838-A6BBB8E2-F371-483A-93DD-62E26B425046Q37707609-7E588783-B4CC-4DB5-A4FF-CDDBCB87FDBAQ37771775-ABF96619-D896-402B-BB6C-3C85BF160E09Q37825589-1754B854-8015-4E9A-B752-D0453607D941Q37858108-28D2DCAE-9E46-4C58-865C-F968885D89C8Q37994893-B59D8DF2-9644-44FD-BCAD-A6F5783244CDQ38112030-BD19384C-AAD3-4DBA-AD4E-E5FF63963552Q38887825-6BAD6CE7-041D-4FF2-A62B-7556747D503BQ40038196-C422E685-0B11-4D30-A39D-D802922777A4Q40661898-21F2EB3B-E168-4DB8-8667-9D836327ED4FQ40803661-045D2CBA-C454-4F98-92A7-A17A84301F1BQ41702589-7F6AE96B-6F66-4CBF-8008-466FEE800D2EQ42102290-CE43F345-E08B-4142-A907-368724B1FB8FQ42515762-021554E8-BE38-4DB7-BEE3-B51CDBF9A90FQ42799009-5EEA4014-1BC6-4341-924C-6626D4D19C09Q42830411-41D2FAA7-2A94-428E-AADF-1A4E6C69D490Q42909637-2E6FD8E5-12F7-406F-8356-365AF33F3EEEQ47651769-BF77C032-1C05-4F20-A300-EE4AEC9BA926Q47721996-CE51B1CB-0E76-43BF-8891-85C2599073FDQ47934955-54671BFF-93C2-4B42-9695-0911420ED565
P2860
Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Hepatocyte growth factor and k ...... gic and clinical significance.
@en
Hepatocyte growth factor and k ...... gic and clinical significance.
@nl
type
label
Hepatocyte growth factor and k ...... gic and clinical significance.
@en
Hepatocyte growth factor and k ...... gic and clinical significance.
@nl
prefLabel
Hepatocyte growth factor and k ...... gic and clinical significance.
@en
Hepatocyte growth factor and k ...... gic and clinical significance.
@nl
P2093
P2860
P1476
Hepatocyte growth factor and k ...... gic and clinical significance.
@en
P2093
Matthay MA
McCormick-Shannon K
Verghese GM
P2860
P304
P356
10.1164/AJRCCM.158.2.9711111
P407
P577
1998-08-01T00:00:00Z